Loading…
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16
HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer Department of Pathology, Free University Hospital, Amsterdam, The Netherlands. To investigate whether there is an association between local or systemic IgG and IgA responses agains...
Saved in:
Published in: | Journal of general virology 1999-02, Vol.80 (2), p.409-417 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3 |
---|---|
cites | |
container_end_page | 417 |
container_issue | 2 |
container_start_page | 409 |
container_title | Journal of general virology |
container_volume | 80 |
creator | Bontkes, HJ de Gruijl, TD Walboomers, JM Schiller, JT Dillner, J Helmerhorst, TJ Verheijen, RH Scheper, RJ Meijer, CJ |
description | HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
To investigate whether there is an association between local or systemic
IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like
particles (VLP) containing L1 and L2 and the possible influence of these
responses on clearance of HPV-16 and its associated lesions, cervical mucus
samples from 125 patients and plasma samples from 100 patients, all
participating in a non-intervention cohort study of women with abnormal
cytology, were analysed. The results show that local IgG and IgA HPV-16
VLP-specific antibodies do not correlate with virus clearance. However,
systemic IgG responses were more frequently detected in patients with a
persistent infection (11/24) compared with patients with cleared HPV-16
infections (3/28, P = 0.006). Furthermore, the ultimate development of
high-grade lesions was associated with systemic VLP-specific IgG reactivity
(P = 0.026). By contrast, systemic IgA responses were correlated with virus
clearance (7/28 clearance compared with 1/24 persistence patients, P =
0.06). This correlation was statistically significant when only those
clearance patients who tested HPV-16 DNA-positive at more than one visit
were included in the analysis (5/11 compared with 1/24, P = 0.007). As
these systemic IgA responses were not accompanied by local IgA responses,
the systemic IgA responses in HPV-16 clearance patients are suggested to be
a by-product of a successful cellular immune response induced at the local
lymph nodes, mediated by cytokines. |
doi_str_mv | 10.1099/0022-1317-80-2-409 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_606253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17295165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3</originalsourceid><addsrcrecordid>eNqFksuOFCEUhitG44yjL-DCsPKyoIWiistyMlGnk0k08bIlFHW6G4cqSqCm02_ro0jbbTsb4wo4fP_PyeGvqueULChR6i0hdY0powJLgmvcEPWgOqcNb3Fdrh9W5yfgrHqS0ndCaNO04nF1RgkRTBB6Xv1cDsM8AoqQpjAmSMisjRtTRpt5MCOazOS8D4O5c3FO6PX1p29vUN5NgChHv2vYu1soXMzO-qJ3IzLIhk2IGaU89zsUVmgbBhjR1uUNshDvnDW-gDkamEoNvCvnEcLkTXJmgZbLBfq8SxkGZ1E3ZzSGjHzYq5bry3vN2hAjeJPh6O3BRDNa2L9ZWsWUP60erYxP8Oy4XlRf37_7cnWNbz5-WF5d3mDbqDpjbgVAb5ngQoBUjBjGJbGkX3VMKiIttWV2qu6osFQSKlQjWGNkJ01vOQN2UeGDb9rCNHd6im4wcaeDcfpYui070JzwumWFF__kpxj6v6I_QqpaJhtZlC8PyoL9mCFlPbhkwXtTJjgnzRWnpTfyX5CKWrWUtwWsD6CNIaUIq1M3lOh91PQ-SXqfJC2JrnWJWhG9OLrP3QD9PckhWwV4dQA2br3Zugh6DWP50Bg6F3TJzsnqFxlu4ZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17295165</pqid></control><display><type>article</type><title>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</title><source>Freely Accessible Science Journals - check A-Z of ejournals</source><creator>Bontkes, HJ ; de Gruijl, TD ; Walboomers, JM ; Schiller, JT ; Dillner, J ; Helmerhorst, TJ ; Verheijen, RH ; Scheper, RJ ; Meijer, CJ</creator><creatorcontrib>Bontkes, HJ ; de Gruijl, TD ; Walboomers, JM ; Schiller, JT ; Dillner, J ; Helmerhorst, TJ ; Verheijen, RH ; Scheper, RJ ; Meijer, CJ</creatorcontrib><description>HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
To investigate whether there is an association between local or systemic
IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like
particles (VLP) containing L1 and L2 and the possible influence of these
responses on clearance of HPV-16 and its associated lesions, cervical mucus
samples from 125 patients and plasma samples from 100 patients, all
participating in a non-intervention cohort study of women with abnormal
cytology, were analysed. The results show that local IgG and IgA HPV-16
VLP-specific antibodies do not correlate with virus clearance. However,
systemic IgG responses were more frequently detected in patients with a
persistent infection (11/24) compared with patients with cleared HPV-16
infections (3/28, P = 0.006). Furthermore, the ultimate development of
high-grade lesions was associated with systemic VLP-specific IgG reactivity
(P = 0.026). By contrast, systemic IgA responses were correlated with virus
clearance (7/28 clearance compared with 1/24 persistence patients, P =
0.06). This correlation was statistically significant when only those
clearance patients who tested HPV-16 DNA-positive at more than one visit
were included in the analysis (5/11 compared with 1/24, P = 0.007). As
these systemic IgA responses were not accompanied by local IgA responses,
the systemic IgA responses in HPV-16 clearance patients are suggested to be
a by-product of a successful cellular immune response induced at the local
lymph nodes, mediated by cytokines.</description><identifier>ISSN: 0022-1317</identifier><identifier>EISSN: 1465-2099</identifier><identifier>DOI: 10.1099/0022-1317-80-2-409</identifier><identifier>PMID: 10073701</identifier><language>eng</language><publisher>England: Soc General Microbiol</publisher><subject>Adolescent ; Adult ; Antibodies, Viral - biosynthesis ; Capsid - immunology ; Capsid Proteins ; Cervical Intraepithelial Neoplasia - complications ; Cervical Intraepithelial Neoplasia - immunology ; Cervical Intraepithelial Neoplasia - virology ; Cohort Studies ; DNA, Viral - isolation & purification ; Female ; Follow-Up Studies ; Human papillomavirus 16 ; Humans ; Immunity, Cellular ; Immunoglobulin A - biosynthesis ; Immunoglobulin G - biosynthesis ; Medicin och hälsovetenskap ; Middle Aged ; Oncogene Proteins, Viral - immunology ; Papillomaviridae - classification ; Papillomaviridae - immunology ; Papillomaviridae - pathogenicity ; Papillomavirus Infections - complications ; Papillomavirus Infections - immunology ; Tumor Virus Infections - complications ; Tumor Virus Infections - immunology ; Uterine Cervical Neoplasms - complications ; Uterine Cervical Neoplasms - immunology ; Uterine Cervical Neoplasms - virology</subject><ispartof>Journal of general virology, 1999-02, Vol.80 (2), p.409-417</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10073701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1953848$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Bontkes, HJ</creatorcontrib><creatorcontrib>de Gruijl, TD</creatorcontrib><creatorcontrib>Walboomers, JM</creatorcontrib><creatorcontrib>Schiller, JT</creatorcontrib><creatorcontrib>Dillner, J</creatorcontrib><creatorcontrib>Helmerhorst, TJ</creatorcontrib><creatorcontrib>Verheijen, RH</creatorcontrib><creatorcontrib>Scheper, RJ</creatorcontrib><creatorcontrib>Meijer, CJ</creatorcontrib><title>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</title><title>Journal of general virology</title><addtitle>J Gen Virol</addtitle><description>HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
To investigate whether there is an association between local or systemic
IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like
particles (VLP) containing L1 and L2 and the possible influence of these
responses on clearance of HPV-16 and its associated lesions, cervical mucus
samples from 125 patients and plasma samples from 100 patients, all
participating in a non-intervention cohort study of women with abnormal
cytology, were analysed. The results show that local IgG and IgA HPV-16
VLP-specific antibodies do not correlate with virus clearance. However,
systemic IgG responses were more frequently detected in patients with a
persistent infection (11/24) compared with patients with cleared HPV-16
infections (3/28, P = 0.006). Furthermore, the ultimate development of
high-grade lesions was associated with systemic VLP-specific IgG reactivity
(P = 0.026). By contrast, systemic IgA responses were correlated with virus
clearance (7/28 clearance compared with 1/24 persistence patients, P =
0.06). This correlation was statistically significant when only those
clearance patients who tested HPV-16 DNA-positive at more than one visit
were included in the analysis (5/11 compared with 1/24, P = 0.007). As
these systemic IgA responses were not accompanied by local IgA responses,
the systemic IgA responses in HPV-16 clearance patients are suggested to be
a by-product of a successful cellular immune response induced at the local
lymph nodes, mediated by cytokines.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antibodies, Viral - biosynthesis</subject><subject>Capsid - immunology</subject><subject>Capsid Proteins</subject><subject>Cervical Intraepithelial Neoplasia - complications</subject><subject>Cervical Intraepithelial Neoplasia - immunology</subject><subject>Cervical Intraepithelial Neoplasia - virology</subject><subject>Cohort Studies</subject><subject>DNA, Viral - isolation & purification</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Human papillomavirus 16</subject><subject>Humans</subject><subject>Immunity, Cellular</subject><subject>Immunoglobulin A - biosynthesis</subject><subject>Immunoglobulin G - biosynthesis</subject><subject>Medicin och hälsovetenskap</subject><subject>Middle Aged</subject><subject>Oncogene Proteins, Viral - immunology</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - immunology</subject><subject>Papillomaviridae - pathogenicity</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - immunology</subject><subject>Tumor Virus Infections - complications</subject><subject>Tumor Virus Infections - immunology</subject><subject>Uterine Cervical Neoplasms - complications</subject><subject>Uterine Cervical Neoplasms - immunology</subject><subject>Uterine Cervical Neoplasms - virology</subject><issn>0022-1317</issn><issn>1465-2099</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFksuOFCEUhitG44yjL-DCsPKyoIWiistyMlGnk0k08bIlFHW6G4cqSqCm02_ro0jbbTsb4wo4fP_PyeGvqueULChR6i0hdY0powJLgmvcEPWgOqcNb3Fdrh9W5yfgrHqS0ndCaNO04nF1RgkRTBB6Xv1cDsM8AoqQpjAmSMisjRtTRpt5MCOazOS8D4O5c3FO6PX1p29vUN5NgChHv2vYu1soXMzO-qJ3IzLIhk2IGaU89zsUVmgbBhjR1uUNshDvnDW-gDkamEoNvCvnEcLkTXJmgZbLBfq8SxkGZ1E3ZzSGjHzYq5bry3vN2hAjeJPh6O3BRDNa2L9ZWsWUP60erYxP8Oy4XlRf37_7cnWNbz5-WF5d3mDbqDpjbgVAb5ngQoBUjBjGJbGkX3VMKiIttWV2qu6osFQSKlQjWGNkJ01vOQN2UeGDb9rCNHd6im4wcaeDcfpYui070JzwumWFF__kpxj6v6I_QqpaJhtZlC8PyoL9mCFlPbhkwXtTJjgnzRWnpTfyX5CKWrWUtwWsD6CNIaUIq1M3lOh91PQ-SXqfJC2JrnWJWhG9OLrP3QD9PckhWwV4dQA2br3Zugh6DWP50Bg6F3TJzsnqFxlu4ZA</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Bontkes, HJ</creator><creator>de Gruijl, TD</creator><creator>Walboomers, JM</creator><creator>Schiller, JT</creator><creator>Dillner, J</creator><creator>Helmerhorst, TJ</creator><creator>Verheijen, RH</creator><creator>Scheper, RJ</creator><creator>Meijer, CJ</creator><general>Soc General Microbiol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>19990201</creationdate><title>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</title><author>Bontkes, HJ ; de Gruijl, TD ; Walboomers, JM ; Schiller, JT ; Dillner, J ; Helmerhorst, TJ ; Verheijen, RH ; Scheper, RJ ; Meijer, CJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibodies, Viral - biosynthesis</topic><topic>Capsid - immunology</topic><topic>Capsid Proteins</topic><topic>Cervical Intraepithelial Neoplasia - complications</topic><topic>Cervical Intraepithelial Neoplasia - immunology</topic><topic>Cervical Intraepithelial Neoplasia - virology</topic><topic>Cohort Studies</topic><topic>DNA, Viral - isolation & purification</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Human papillomavirus 16</topic><topic>Humans</topic><topic>Immunity, Cellular</topic><topic>Immunoglobulin A - biosynthesis</topic><topic>Immunoglobulin G - biosynthesis</topic><topic>Medicin och hälsovetenskap</topic><topic>Middle Aged</topic><topic>Oncogene Proteins, Viral - immunology</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - immunology</topic><topic>Papillomaviridae - pathogenicity</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - immunology</topic><topic>Tumor Virus Infections - complications</topic><topic>Tumor Virus Infections - immunology</topic><topic>Uterine Cervical Neoplasms - complications</topic><topic>Uterine Cervical Neoplasms - immunology</topic><topic>Uterine Cervical Neoplasms - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bontkes, HJ</creatorcontrib><creatorcontrib>de Gruijl, TD</creatorcontrib><creatorcontrib>Walboomers, JM</creatorcontrib><creatorcontrib>Schiller, JT</creatorcontrib><creatorcontrib>Dillner, J</creatorcontrib><creatorcontrib>Helmerhorst, TJ</creatorcontrib><creatorcontrib>Verheijen, RH</creatorcontrib><creatorcontrib>Scheper, RJ</creatorcontrib><creatorcontrib>Meijer, CJ</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Journal of general virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bontkes, HJ</au><au>de Gruijl, TD</au><au>Walboomers, JM</au><au>Schiller, JT</au><au>Dillner, J</au><au>Helmerhorst, TJ</au><au>Verheijen, RH</au><au>Scheper, RJ</au><au>Meijer, CJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16</atitle><jtitle>Journal of general virology</jtitle><addtitle>J Gen Virol</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>80</volume><issue>2</issue><spage>409</spage><epage>417</epage><pages>409-417</pages><issn>0022-1317</issn><eissn>1465-2099</eissn><abstract>HJ Bontkes, TD de Gruijl, JM Walboomers, JT Schiller, J Dillner, TJ Helmerhorst, RH Verheijen, RJ Scheper and CJ Meijer
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
To investigate whether there is an association between local or systemic
IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like
particles (VLP) containing L1 and L2 and the possible influence of these
responses on clearance of HPV-16 and its associated lesions, cervical mucus
samples from 125 patients and plasma samples from 100 patients, all
participating in a non-intervention cohort study of women with abnormal
cytology, were analysed. The results show that local IgG and IgA HPV-16
VLP-specific antibodies do not correlate with virus clearance. However,
systemic IgG responses were more frequently detected in patients with a
persistent infection (11/24) compared with patients with cleared HPV-16
infections (3/28, P = 0.006). Furthermore, the ultimate development of
high-grade lesions was associated with systemic VLP-specific IgG reactivity
(P = 0.026). By contrast, systemic IgA responses were correlated with virus
clearance (7/28 clearance compared with 1/24 persistence patients, P =
0.06). This correlation was statistically significant when only those
clearance patients who tested HPV-16 DNA-positive at more than one visit
were included in the analysis (5/11 compared with 1/24, P = 0.007). As
these systemic IgA responses were not accompanied by local IgA responses,
the systemic IgA responses in HPV-16 clearance patients are suggested to be
a by-product of a successful cellular immune response induced at the local
lymph nodes, mediated by cytokines.</abstract><cop>England</cop><pub>Soc General Microbiol</pub><pmid>10073701</pmid><doi>10.1099/0022-1317-80-2-409</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1317 |
ispartof | Journal of general virology, 1999-02, Vol.80 (2), p.409-417 |
issn | 0022-1317 1465-2099 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_606253 |
source | Freely Accessible Science Journals - check A-Z of ejournals |
subjects | Adolescent Adult Antibodies, Viral - biosynthesis Capsid - immunology Capsid Proteins Cervical Intraepithelial Neoplasia - complications Cervical Intraepithelial Neoplasia - immunology Cervical Intraepithelial Neoplasia - virology Cohort Studies DNA, Viral - isolation & purification Female Follow-Up Studies Human papillomavirus 16 Humans Immunity, Cellular Immunoglobulin A - biosynthesis Immunoglobulin G - biosynthesis Medicin och hälsovetenskap Middle Aged Oncogene Proteins, Viral - immunology Papillomaviridae - classification Papillomaviridae - immunology Papillomaviridae - pathogenicity Papillomavirus Infections - complications Papillomavirus Infections - immunology Tumor Virus Infections - complications Tumor Virus Infections - immunology Uterine Cervical Neoplasms - complications Uterine Cervical Neoplasms - immunology Uterine Cervical Neoplasms - virology |
title | Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A09%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20responses%20against%20human%20papillomavirus%20(HPV)%20type%2016%20virus-like%20particles%20in%20a%20cohort%20study%20of%20women%20with%20cervical%20intraepithelial%20neoplasia.%20II.%20Systemic%20but%20not%20local%20IgA%20responses%20correlate%20with%20clearance%20of%20HPV-16&rft.jtitle=Journal%20of%20general%20virology&rft.au=Bontkes,%20HJ&rft.date=1999-02-01&rft.volume=80&rft.issue=2&rft.spage=409&rft.epage=417&rft.pages=409-417&rft.issn=0022-1317&rft.eissn=1465-2099&rft_id=info:doi/10.1099/0022-1317-80-2-409&rft_dat=%3Cproquest_swepu%3E17295165%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-6c7eedc37677e8930a3680c0dfb38908c1c44592b17c1801794734a8b8adc63e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17295165&rft_id=info:pmid/10073701&rfr_iscdi=true |